Lion's mane (Hericium erinaceus) is the only edible mushroom known to stimulate nerve growth factor (NGF) synthesis in the brain. Here is what the clinical evidence actually shows — and what it does not yet prove.
For educational purposes only — not medical advice. How we evaluate evidence →
Reviewed by
Dr. A. Ferreira, MDGeneral practitioner with integrative medicine training. Reviewed for factual accuracy. This article is for educational purposes only and does not constitute medical advice.
Last reviewed
This article is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before making health decisions. Our editorial standards →
Lion's mane mushroom (Hericium erinaceus) has attracted serious scientific attention for a property that no other culinary mushroom shares: the ability to stimulate the synthesis of nerve growth factor (NGF) — a protein essential for the growth, maintenance, and survival of neurons. Two classes of bioactive compounds unique to lion's mane — hericenones (found in the fruiting body) and erinacines (found in the mycelium) — have been shown in laboratory and animal studies to cross the blood-brain barrier and upregulate NGF expression. This mechanism has made lion's mane one of the most studied natural compounds in the emerging field of neuroregeneration.
The Clinical Evidence: What Human Trials Show. The most cited human trial is a double-blind, placebo-controlled study by Mori et al. (Phytotherapy Research, 2009) involving 30 Japanese adults aged 50–80 with mild cognitive impairment (MCI). Participants received 3g/day of lion's mane powder for 16 weeks. The lion's mane group showed significantly higher scores on the Hasegawa Dementia Scale compared to placebo — but scores declined back toward baseline after supplementation stopped. A 2020 pilot RCT by Saitsu et al. (Biomedical Research, 2019) found improvements in cognitive function in 31 older adults with MCI after 12 weeks of lion's mane supplementation. A 2023 RCT by Docherty et al. (Nutritional Neuroscience) found that a single dose of lion's mane extract improved speed of performance on cognitive tasks in healthy young adults within 60 minutes. These are promising signals, but the trials are small, short-duration, and use different preparations and doses — making firm conclusions premature.
Neurogenesis: The Bigger Picture. Neurogenesis — the birth of new neurons — was long believed to occur only during fetal development. We now know that the adult brain retains the capacity for neurogenesis, primarily in the hippocampus (the memory and learning centre) and the olfactory bulb. NGF and its close relative BDNF (brain-derived neurotrophic factor) are the key molecular signals that support this process. Lion's mane's ability to upregulate NGF makes it theoretically relevant to conditions involving neurodegeneration — Alzheimer's disease, Parkinson's disease, peripheral neuropathy — but the leap from 'stimulates NGF in cell cultures and rodents' to 'treats or prevents neurodegeneration in humans' is large, and the clinical evidence has not yet closed that gap.
Mood and Anxiety: An Unexpected Finding. A 2010 double-blind, placebo-controlled trial by Nagano et al. (Biomedical Research) found that 30 women who consumed lion's mane cookies for 4 weeks reported significantly lower scores on measures of depression, anxiety, and irritability compared to placebo. The proposed mechanism involves NGF's role in the enteric nervous system and the gut-brain axis, as well as direct effects on hippocampal neurogenesis — which is impaired in depression. This is a small, single study, but it aligns with the broader evidence that neurotrophin support has antidepressant effects.
Dosing, Forms, and Practical Guidance. Most clinical trials have used 3–5g/day of dried lion's mane powder, or 500–1000mg of a standardised extract (typically standardised to hericenones or beta-glucan content). The mycelium-based products contain higher concentrations of erinacines; fruiting body products contain more hericenones — both appear to have NGF-stimulating activity. Lion's mane is generally well tolerated; the most commonly reported side effects are mild gastrointestinal discomfort. It can be consumed as a culinary mushroom (the fresh mushroom has a seafood-like texture and mild flavour), as a powder added to coffee or smoothies, or as a capsule supplement. Effects on cognition appear to require consistent use over weeks to months — it is not an acute nootropic in the way caffeine is.
The current evidence base for lion's mane in humans is promising but limited. We do not yet know: the optimal dose and duration for cognitive benefit; whether effects are sustained with long-term use; whether it is effective in people with established Alzheimer's or Parkinson's disease (most trials have focused on MCI or healthy aging); or how it compares to other NGF-supporting interventions (exercise, sleep, omega-3). Larger, longer, well-controlled RCTs are needed before lion's mane can be recommended as a treatment for any neurological condition.
Personalised plan
Get a personalised brain health and cognitive care plan.
Seen a claim you want to verify?
The Claim Decoder grades the evidence behind any natural health claim — A to F, with sources.
Suggested from this article:
"Lion's mane mushroom stimulates nerve growth factor in humans"
Prompted by: Lion's Mane Mushroom and Neurogenesis: What the Evidence Shows
The MIND diet reduces Alzheimer's risk by up to 53% in adherent individuals. Here is what the evidence says about food, brain aging, and cognitive decline — and the practical eating pattern that protects the most.
Omega-3s, lion's mane, phosphatidylserine, B vitamins, and vitamin D all have research behind them for cognitive health. Here is an honest look at what the evidence actually supports — and what it does not.
Regular aerobic exercise reduces dementia risk by 30–40% in large cohort studies. A landmark twin study found leg-focused resistance training produced a 47% improvement in cognitive performance. It also grows the hippocampus, increases BDNF, and clears amyloid. Here is the evidence — and the minimum effective dose.
